CD163 and neoplasm: A high level of CD163+ TAMs (M2) was found to be associated with worse prognosis and higher tumor stage in NSCLC (95), whereas in penile cancer, a high level of CD163+ TAMs was associated with increased LNM rather than poor survival (68).